Study for genetic eye surface stem cell problems
Part of Eyes & vision, Genetic & congenital clinical trials.
This trial studies people whose eye surface problems are caused by an inherited (genetic) condition. It aims to better understand how specific genetic changes relate to symptoms, which may guide more personalized care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a genetic (inherited) condition affecting the surface of your eye
- Your main eye problem is not mainly from damage to the retina (the back of the eye)
- You are not currently pregnant
- You are not breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment that uses your own eye cells to repair the surface of the eye. It may help if you have severe damage to the clear front layer of your eye.
This trial tests an eye treatment made from your own cornea surface cells, grown in a lab and put back into the eye. It may help people with limbal stem cell deficiency by improving the health of the eye surface after a cell biopsy.
This study looks at people with diseases of the eye surface (the clear front part of the eye) to find out which factors predict how well their vision will be after treatment. By joining, you help researchers learn more about these conditions and what may affect visual recovery.
This observational study follows patients with limbal stem cell deficiency (a condition affecting cells at the edge of the cornea that help maintain healthy eye surface) to understand how their vision changes over time. Researchers will track your eye health without giving you new treatment.
This study looks at how glaucoma and its treatments affect the surface of the eye and proteins in tears. It may help find better ways to manage eye health in people with glaucoma.
This study tests a new eye drop called CSB-001 for people with limbal stem cell deficiency (LSCD), a condition that damages the cornea. The goal is to see if the drops can help improve the health of the cornea and reduce inflammation.
Hear when a new Limbus Corneae trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.